This might be based on the fact that GBM has a significantly higher hypoxic nature compared to LGG (see hypoxia scores in Figure 7A vs. 7B) therefore hypoxia may not be the dominant regulator for TXNDC5 expression in LGG tumors and other regulatory mechanisms might be involved. The gene discussed is TXNDC5; the disease is glioblastoma.